The Year Ahead: The Trump Administration On Prescription Drug Pricing

By Rachel Cohrs / January 3, 2019 at 5:54 PM
The Trump administration is expected to keep drug pricing on center stage in 2019 following a flurry of action last year. In 2018, the administration released a 44-page blueprint with ideas and questions on potential ways to lower drug prices and reduce out-of-pocket costs, and HHS, FDA and CMS proposed a torrent of regulations and notices. The pace in 2019 shows no sign of slowing as more information emerges about current proposals and officials continue to introduce new ideas. Overall,...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.